IBA Proton Therapy

21/10/2025

A must-attend event for the scientific community:

The latest results from a randomized multicenter Phase III study comparing Intensity-Modulated Proton Therapy (IMPT) with Intensity-Modulated Photon Therapy (IMRT) in the treatment of oropharyngeal carcinoma will be presented.

Special guest:
Steven J. Frank, Professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center, Houston (Texas).

🗓️ November 13, 2025 | 12:00 – 14:00
📌 Starhotels Metropole, Via Principe Amedeo 3, Rome

Register here: https://form.jotform.com/252881701012347

20/10/2025

“The primary endpoint is to reduce major cardiac events. […] Major cardiac events are quite debilitating, life threatening and life altering.”

🌸🎗 As part of Breast Cancer Awareness Month, we continue our special video series with Dr. Shannon MacDonald, the clinical chair of RadComp and medical director of the Southwest Florida Proton Center, who shares the purpose behind the ongoing clinical trial studying proton therapy for breast cancer.

S.M. MacDonald & Al. - Phase III randomized trial of proton vs. photon therapy for patients with non-metastatic breast cancer receiving comprehensive nodal radiation: A radiotherapy comparative effectiveness (RadComp) Consortium Trial: Health-related quality of life outcomes - ASTRO2025).

👉 Watch the full series on our YouTube channel to see how proton therapy is advancing breast cancer treatment: youtube.com/watch?si=zJIkkM_yZKz5T5UR&v=z_f1AH59x-o&feature=youtu.be

17/10/2025

🌸🎗 “In the past, proton therapy had been used for partial breast irradiation. […] But no one had yet used it for locally advanced breast cancer, which was in my opinion, arguably a much better indication.”

As part of Breast Cancer Awareness Month, we are launching a special video series featuring Dr. Shannon MacDonald, the clinical chair of RadComp and medical director of the Southwest Florida Proton Center, who shares how her pioneering work with proton therapy has opened new possibilities in breast cancer treatment.

S.M. MacDonald & Al. - Phase III randomized trial of proton vs. photon therapy for patients with non-metastatic breast cancer receiving comprehensive nodal radiation: A radiotherapy comparative effectiveness (RadComp) Consortium Trial: Health-related quality of life outcomes - ASTRO2025).

👉 Watch the full series on our YouTube channel to see how proton therapy is advancing breast cancer treatment: https://www.youtube.com/watch?v=d5xWMSBDJh0

15/10/2025

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗮𝗻 𝗜𝗕𝗔 𝗣𝗿𝗼𝘁𝗲𝘂𝘀 𝗨𝘀𝗲𝗿? Don’t miss the 𝗣𝗿𝗼𝘁𝗲𝘂𝘀 𝗨𝘀𝗲𝗿 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 in Belgium!
Get ready for an unforgettable edition gathering the IBA Proteus Community.

📅 April 24–26, 2026
📍 Dolce La Hulpe Brussels

This exclusive event marks two major milestones:
🎉 25 years of patient treatments on Proteus - the first patient treated at Mass General Brigham
🎉 40 years of proton therapy innovation at IBA

Join us for a unique opportunity to collaborate, share knowledge, network, and engage in strategic discussions.

Watch Yves Jongen’s personal invitation below.

Spots are filling fast — register now!
👉 https://go.iba-worldwide.com/l/928513/2025-09-10/bkwkpw

29/09/2025

Excited to be at ASTRO 2025 in San Francisco!
Come visit us at booth #2013 to discover our latest innovations and enjoy a warm cup of coffee ☕.

📢 Don’t miss the insightful talk by Steven Frank on 𝗠𝗼𝗻𝗱𝗮𝘆 𝗮𝘁 𝟭𝟬:𝟭𝟱 𝗔𝗠, right at our booth for a talk about 𝗽𝗿𝗼𝘁𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗳𝗼𝗿 𝗵𝗲𝗮𝗱 𝗮𝗻𝗱 𝗻𝗲𝗰𝗸 𝗰𝗮𝗻𝗰𝗲𝗿.
Together, 𝗹𝗲𝘁’𝘀 𝗯𝗿𝗶𝗱𝗴𝗲 𝘁𝗵𝗲 𝗽𝗿𝗼𝘁𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗴𝗮𝗽 and advance cancer care through collaboration and innovation.

29/09/2025

Varian, a Siemens Healthineers company, and IBA Proton Therapy have entered into a Memorandum of Understanding to evaluate areas for strategic collaboration with the aim to strengthen interoperability and enhance clinical workflows in proton therapy, supporting our shared mission of improving access to care.

🌀 Eclipse and Proteus®ONE Compatibility – Varian’s Eclipse treatment planning system is now seamlessly compatible with IBA’s Proteus®ONE platform, enabling clinicians to streamline planning and delivery with optimized workflows.

🖼️ Launching DynamicARC® Planning in Eclipse – Both Varian and IBA are evaluating future possibilities for arc-based proton therapy planning in Eclipse. This collaboration aims to explore opportunities in treatment personalization and delivery efficiency, while continuing to advance current innovations across our platforms.

⚡Next-Generation Imaging in Proton Therapy – Together, IBA and Varian will explore co-developing advanced imaging solutions to enhance accuracy and confidence in patient positioning.

🧠 FLASH Therapy Quality Assurance – Joint efforts are underway to explore opportunities in quality assurance practices that may help enable future clinical implementation of FLASH therapy.

This developing collaboration underscores a shared commitment to expanding access, strengthening clinical workflows, and advancing intelligent cancer care. 🤝 Learn more at

* Flash therapy is under development and not available for sale. The products/features mentioned here are not commercially available in all countries. Their future availability cannot be guaranteed.
QR700029693

20/08/2025

We are proud to announce that we have signed a 𝗰𝗼𝗻𝘁𝗿𝗮𝗰𝘁 to install a 𝗣𝗿𝗼𝘁𝗲𝘂𝘀®𝗢𝗡𝗘 compact proton therapy solution to be located on the University campus in 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴, 𝗚𝗲𝗿𝗺𝗮𝗻𝘆.
The acquisition of this ProteusONE system marks a strategic expansion of Universitätsklinikum Heidelberg (UKHD)'s particle therapy program, which has been treating patients since 2010, ensuring continued access to cutting-edge, highly targeted treatment for patients with cancer using the latest techniques in proton therapy. This investment further strengthens UKHD’s role as a global reference center for precision radiation oncology, combining scientific excellence with patient-centered innovation.

👉 Read the full press release here: https://www.iba-worldwide.com/heidelberg-university-hospital-expands-its-particle-therapy-program-ibas-proteusrone-solution

15/07/2025

Have you heard of proton therapy, but are not quite sure how it works?

Our short and simple video explains everything!

Watch it here and share with someone who might find it helpful 👇

08/07/2025

💡 How does Proton Therapy work? Our newest video simplifies the science behind one of the most precise cancer treatments available today.[1]

In less than 3 minutes, understand how proton therapy targets tumors while sparing healthy tissue.[2]



[1] Baumann BC, et al. Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer. JAMA Oncol. 2020;6(2):237-246.

[2] Mohan R. A Review of Proton Therapy - Current Status and Future Directions. Precis Radiat Oncol. 2022 Jun;6(2):164-176.

08/05/2025

🚀 The Strong Partnership Between Proton Therapy Providers and Clinical Centers


As Dr. Anthony Zietman from Massachusetts General Hospital explains, the collaboration between a proton therapy provider and a clinical center is built on trust and mutual commitment, and it plays a pivotal role in advancing patient care.

In this insightful discussion, Dr. Zietman emphasizes the importance of selecting the right proton therapy partner—one that not only meets today's needs but also supports future advancements in radiation oncology. 🌱

Choosing the right partner isn’t just a decision for today; it’s a choice for tomorrow’s breakthroughs in proton therapy.

Let’s continue to advance patient care with the right collaborations. 🔗



🔗 Learn More 👇

18/04/2025

In honor of 🌟Head & Neck Cancer Awareness Month🌟, we want to highlight again the groundbreaking research of Dr. Steven Frank from MD Anderson Cancer Center. His work provides Level 1 evidence that 𝐩𝐫𝐨𝐭𝐨𝐧 𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐟𝐨𝐫 𝐨𝐫𝐨𝐩𝐡𝐚𝐫𝐲𝐧𝐠𝐞𝐚𝐥 𝐜𝐚𝐧𝐜𝐞𝐫 𝐚𝐜𝐡𝐢𝐞𝐯𝐞𝐬 𝐬𝐢𝐦𝐢𝐥𝐚𝐫 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐰𝐡𝐢𝐥𝐞 𝐬𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭𝐥𝐲 𝐫𝐞𝐝𝐮𝐜𝐢𝐧𝐠 𝐬𝐢𝐝𝐞 𝐞𝐟𝐟𝐞𝐜𝐭𝐬 compared to photon-based radiotherapy.

This research is a game-changer in the field, offering hope and improved quality of life for patients. Let's continue to support and share these advancements in cancer treatment! 💪

📚 Read more on Campus 👉 https://www.campus-iba.com/publications/phase-iii-randomized-trial-intensity-modulated-proton-therapy-impt-versus-intensity

15/04/2025

Celebrating 25+ Years of Innovation and Collaboration with MGH! 🌟

We are thrilled to continue our long-standing partnership with Massachusetts General Hospital (MGH), the original and largest teaching hospital of Harvard Medical School ! Over the past 25 years, we have worked hand-in-hand to push the boundaries of medical care, and now, we are celebrating a major milestone.

Together, we are in the process of completing the full refurbishment of the first-ever proton therapy system at MGH! 💡 This is a groundbreaking achievement that not only honors our history but also sets the stage for an exciting future in sustainable proton therapy (PT).

We are excited about the new possibilities we are embracing in the field of radiation oncology, and we are committed to delivering best-in-class patient care through innovative technologies.

Here’s to more milestones, more progress, and more lives improved! 🙌🏼✨

🔗 Learn More 👇🏼
https://www.youtube.com/watch?v=f_Mx26fngn4

Dr. Helen Shih and Dr. Anthony Zietman from Massachusetts General Hospital (MGH) discuss their roles and the advancements in proton therapy. Dr. Shih is the ...